Dtsch Med Wochenschr 2011; 136(21): 1130-1134
DOI: 10.1055/s-0031-1280525
Prinzip & Perspektive | Review article
Diabetologie
© Georg Thieme Verlag KG Stuttgart · New York

Der Blick in die Betazelle: neue Bildgebungstechniken in der Inselforschung

New perspectives of imaging techniques in islet researchM. Tiedge1 , S. Baltrusch1
  • 1Institut für Medizinische Biochemie und Molekularbiologie, Universität Rostock
Further Information

Publication History

eingereicht: 16.2.2011

akzeptiert: 14.4.2011

Publication Date:
17 May 2011 (online)

Literatur

  • 1 Antkowiak P F, Tersey S A, Carter J D. et al . Noninvasive assessment of pancreatic beta-cell function in vivo with manganese-enhanced magnetic resonance imaging.  Am J Physiol Endocrinol Metab. 2009;  296 E573-578
  • 2 Baltrusch S, Lenzen S. Monitoring of glucose-regulated single insulin secretory granule movement by selective photoactivation.  Diabetologia. 2008;  51 989-996
  • 3 Brom M, Andralojc K, Oyen W J, Boerman O C, Gotthardt M. Development of radiotracers for the determination of the beta-cell mass in vivo.  Curr Pharm Des. 2010;  16 1561-1567
  • 4 Chalfie M, Tu Y, Euskirchen G, Ward W W, Prasher D C. Green fluorescent protein as a marker for gene expression.  Science. 1994;  263 802-805
  • 5 Dyachok O, Isakov Y, Sagetorp J, Tengholm A. Oscillations of cyclic AMP in hormone-stimulated insulin-secreting beta-cells.  Nature. 2006;  439 349-352
  • 6 Egner A, Jakobs S, Hell S W. Fast 100-nm resolution three-dimensional microscope reveals structural plasticity of mitochondria in live yeast.  Proc Natl Acad Sci U S A. 2002;  99 3370-3375
  • 7 Egner A, Geisler C, Middendorff C von. et al . Fluorescence nanoscopy in whole cells by asynchronous localization of photoswitching emitters.  Biophys J. 2007;  93 3285-3290
  • 8 Evgenov N V, Medarova Z, Dai G, Bonner-Weir S, Moore A. In vivo imaging of islet transplantation.  Nat Med. 2006;  12 144-148
  • 9 Giepmans B N, Adams S R, Ellisman M H, Tsien R Y. The fluorescent toolbox for assessing protein location and function.  Science. 2006;  312 217-224
  • 10 Goland R, Freeby M, Parsey R. et al . 11C-dihydrotetrabenazine PET of the pancreas in subjects with long-standing type 1 diabetes and in healthy controls.  J Nucl Med. 2009;  50 382-389
  • 11 Gotthardt M, Fischer M, Naeher I. et al . Use of the incretin hormone glucagon-like peptide-1 (GLP-1) for the detection of insulinomas: initial experimental results.  Eur J Nucl Med Mol Imaging. 2002;  29 597-606
  • 12 Gurskaya N G, Verkhusha V V, Shcheglov A S. et al . Engineering of a monomeric green-to-red photoactivatable fluorescent protein induced by blue light.  Nat Biotechnol. 2006;  24 461-465
  • 13 Hara M, Bindokas V, Lopez J P. et al . Imaging endoplasmic reticulum calcium with a fluorescent biosensor in transgenic mice.  Am J Physiol Cell Physiol. 2004;  287 C932-938
  • 14 Hell S W. Toward fluorescence nanoscopy.  Nat Biotechnol. 2003;  21 1347-1355
  • 15 Lamberts S W, de Herder W W, Kwekkeboom D J, vd Lely A J, Nobels F R, Krenning E P. Current tools in the diagnosis of pituitary tumours.  Acta Endocrinol (Copenh). 1993;  129 Suppl 1 6-12
  • 16 Massoud T F, Gambhir S S. Molecular imaging in living subjects: seeing fundamental biological processes in a new light.  Genes Dev. 2003;  17 545-580
  • 17 Medarova Z, Moore A. MRI as a tool to monitor islet transplantation.  Nat Rev Endocrinol. 2009;  5 444-452
  • 18 Medarova Z, Vallabhajosyula P, Tena A. et al . In vivo imaging of autologous islet grafts in the liver and under the kidney capsule in non-human primates.  Transplantation. 2009;  87 1659-1666
  • 19 Meier J J. Beta cell mass in diabetes: a realistic therapeutic target?.  Diabetologia. 2008;  51 703-713
  • 20 Miyawaki A, Llopis J, Heim R. et al . Fluorescent indicators for Ca2+ based on green fluorescent proteins and calmodulin.  Nature. 1997;  388 882-887
  • 21 Molina A J, Shirihai O S. Monitoring mitochondrial dynamics with photoactivatable [corrected] green fluorescent protein.  Methods Enzymol. 2009;  457 289-304
  • 22 Moore A, Grimm J, Han B, Santamaria P. Tracking the recruitment of diabetogenic CD8+ T-cells to the pancreas in real time.  Diabetes. 2004;  53 1459-1466
  • 23 Palmer A E, Tsien R Y. Measuring calcium signaling using genetically targetable fluorescent indicators.  Nat Protoc. 2006;  1 1057-1065
  • 24 Patterson G H, Lippincott-Schwartz J. A photoactivatable GFP for selective photolabeling of proteins and cells.  Science. 2002;  297 1873-1877
  • 25 Ponsioen B, Zhao J, Riedl J. et al . Detecting cAMP-induced Epac activation by fluorescence resonance energy transfer: Epac as a novel cAMP indicator.  EMBO Rep. 2004;  5 1176-1180
  • 26 Prasher D C, Eckenrode V K, Ward W W, Prendergast F G, Cormier M J. Primary structure of the Aequorea victoria green-fluorescent protein.  Gene. 1992;  111 229-233
  • 27 Rhodes C J. Type 2 diabetes – a matter of beta-cell life and death?.  Science. 2005;  307 380-384
  • 28 Simpson N R, Souza F, Witkowski P. et al . Visualizing pancreatic beta-cell mass with [11C]DTBZ.  Nucl Med Biol. 2006;  33 855-864
  • 29 Toso C, Vallee J P, Morel P. et al . Clinical magnetic resonance imaging of pancreatic islet grafts after iron nanoparticle labeling.  Am J Transplant. 2008;  8 701-706
  • 30 Tsien R. Roger Tsien: bringing color to cell biology. A passion for chemistry, color, and conversations with cells is what drives Roger Tsien. Interview by Ruth Williams.  J Cell Biol. 2007;  179 6-8
  • 31 Tsien R Y. Indicators based on fluorescence resonance energy transfer (FRET).  Cold Spring Harb Protoc. 2009;  2009 pdb top57
  • 32 Twig G, Graf S A, Wikstrom J D. et al . Tagging and tracking individual networks within a complex mitochondrial web with photoactivatable GFP.  Am J Physiol Cell Physiol. 2006;  291 C176-C184
  • 33 Ueberberg S, Meier J J, Waengler C. et al . Generation of novel single-chain antibodies by phage-display technology to direct imaging agents highly selective to pancreatic beta- or alpha-cells in vivo.  Diabetes. 2009;  58 2324-2334
  • 34 Wild D, Macke H, Christ E, Gloor B, Reubi J C. Glucagon-like peptide 1-receptor scans to localize occult insulinomas.  N Engl J Med. 2008;  359 766-768

Prof. Dr. med. Markus Tiedge

Institut für Medizinische Biochemie und Molekularbiologie
Universität Rostock

Schillingallee 70

18057 Rostock

Phone: 0381/4945750

Fax: 0381/4945752

Email: markus.tiedge@med.uni-rostock.de